Pharma Co. Gets First US Patent for Repurposed Drug
Source: Streetwise Reports  (1/2/24)
Clinical-stage pharmaceuticals firm Algernon Pharmaceuticals Inc. has been issued a U.S. patent for the treatment of three related diseases with its investigational drug repirinast. More >

Life Sciences Co. Gets Big Order for Livestock Feed Additive
Source: Joseph Gomes   (8/16/22)
This sale indicates the firm is continuing to forge a pathway into one of its large target markets, noted a Noble Capital Markets report. More >

Dental & Animal Health Supplier Posts 10% Yearly Sales Gains
Source: Streetwise Reports  (6/29/22)
Shares of Patterson Companies Inc. traded 11% higher after the dental supply and animal health products distributor reported Q4/22 and FY/22 financial results highlighting a 9.9% increase in annual sales and an expansion in operating margins. More >

Analyst Says Avivagen Is a Strong Buy
Source: Clive Maund  (5/5/22)
With Avivagen's breakthrough product relishing in its success, Analyst Clive Maund reviews if he believes it is now a formidable contender as a Buy. More >

US DEA OKs Use of Psychedelics by This Mental Health Network
Source: Streetwise Reports  (11/9/21)
Clinics that deliver novel psychiatric treatment and host clinical trials of psychedelic medicine have positioned Novamind for breakthroughs in mental health treatment. More >

Global Distribution Deal for Antibiotic Alternative for Livestock ‘Could Be a Game Changer’
Source: Streetwise Reports  (10/25/21)
Analyst David Bautz at Zacks Small-Cap Research wrote bullishly on Avivagen's eight-year distribution deal targeting the U.S., Brazil, and Thailand in an Oct. 11 report: The AB Vista deal “could be a game changer for the company as Avivagen now has a global partner that gives immediate credibility to the OxC-beta technology." More >

Rritual Superfoods at Full-Throttle, Adding CVS, Amazon Along the US Distribution Superhighway
Source: Knox Henderson for Streetwise Reports  (7/28/21)
Knox Henderson takes a close look at Rritual Superfoods and its plans to ramp up mass distribution. More >

Innovative Life Sciences Company Boosts Immune Function in Livestock Without the Use of Antibiotics
Source: Streetwise Reports  (6/2/21)
Avivagen's OxC-betaâ„¢ Livestock products could play a pivotal role in the global mandate to remove all in-feed antibiotics as growth promoters. More >

Life Sciences Firm Is at 'an Inflection Point with Significant Sales Increases Just around the Corner'
Source: Streetwise Reports  (5/12/21)
Noble Capital Markets noted in a research report that shortly after receiving its largest single order to date, a 4.4-ton order for OxC-beta Livestock, Avivagen Inc. has received a new order for 4 tons per month from its representative in Mexico. More >

Coverage Initiated on Health & Wellness Firm About to Launch Retail Sales, Sees 'Substantial Upside Potential'
Source: Streetwise Reports  (3/30/21)
Clarus Securities' initiation report on Rritual Superfoods views the company "as an attractive growth story for investors looking to gain exposure to a large and rapidly growing functional food and beverages market." More >

Rritual Superfoods Hits the Superhighway to Nationwide Distribution and Impressive Share Gains
Source: Knox Henderson for Streetwise Reports  (3/24/21)
Knox Henderson delves into the value proposition behind Rritual Superfoods, which has just started trading this month. More >

Company's Antibiotic-Free Livestock Feed Product Shows Positive Results in Subclinical Mastitis Dairy Trial
Source: Streetwise Reports  (2/22/21)
Avivagen Inc. reported that data from a New Zealand OxC-betaTâ„¢ Livestock Dairy Trial for use against sub-clinical mastitis has been published in a top-tier international veterinary science journal. More >

Life Sciences Co. Receives Large Livestock Feed Order from New Client in Mexico
Source: Streetwise Reports  (1/27/21)
Avivagen Inc. reported it has secured a six tonne order for OxC-betaâ„¢ Livestock from a new customer in Queretaro City, Mexico. More >

Life Sciences Firm Reports Year of Record Breaking Orders
Source: Streetwise Reports  (12/18/20)
Avivagen Inc. reported FY/20 audited financial results that included a 20.5% increase in YoY revenue. More >

Life Sciences Firm Lands Record 4 Metric Tons Order for Antibiotic-Free Feedstock
Source: Streetwise Reports  (10/14/20)
Avivagen Inc. reported that it has received a record purchase order for its OxC-betaâ„¢ product from UNAHCO. More >

Life Sciences Company Posts Record Q3 Revenue Due to Successful Recurring Purchase Model
Source: Streetwise Reports  (9/9/20)
Avivagen Inc. reported unaudited financial results for Q3/20 that included record revenue and product sales volumes that nearly eclipsed FY/19 levels. More >

Cannabis Cultivator Shifts Focus to Commercializing Technology
Source: Streetwise Reports  (5/18/20)
Sproutly Canada has received capital investment from Infusion Biosciences. More >

Lifeway Foods' Shares Rise 40% on Positive Q1 Sales Data with March Revenue Up 13% Y-O-Y
Source: Streetwise Reports  (4/15/20)
Shares of Lifeway Foods traded higher as the company reported it has increased production to support accelerated demand during the COVID-19 health crisis. More >

Company Secures Largest Order to Date for Antibiotic-Free Feedstock Supplement
Source: Streetwise Reports  (4/8/20)
Avivagen Inc. has secured its largest ever order of OxC-betaâ„¢ Livestock from its long-standing Philippine partner UNAHCO. More >

Maker of Antibiotic-Free Animal Supplement Lands First Order from Mexico
Source: Streetwise Reports  (3/26/20)
This new market is a significant one for Avivagen. More >

Avivagen to Be Featured on BioPub Webcast Hosted by Dr. KSS MD PhD on March 6
Source: Streetwise Reports  (3/5/20)
Webcast will be at 12 noon ET on Friday, March 6. More >

Antibiotic-Free Feed Additive Shows Benefit in Cow Mastitis Trial
Source: Streetwise Reports  (2/24/20)
Avivagen's proprietary product yielded statistically significant results. More >

CEO Reviews Life Sciences Firm's Year of 'Exceptional Accomplishment'
Source: Streetwise Reports  (1/30/20)
The company makes progress getting its products approved and sold in more countries. More >

Life Sciences Firm Upgrades to OTCQB Venture Market
Source: Streetwise Reports  (1/10/20)
This is a significant achievement of this developing company. More >

Agreement Sets Stage to Secure Chinese Approval of Non-Antibiotic Livestock Feed Supplement
Source: Streetwise Reports  (12/18/19)
The requirements include, among others, trials of the company's livestock feed additive. More >